HMGB1 and necrotizing enterocolitis: Studies have shown that exogenous BT can alleviate intestinal pathological damage in NEC by inhibiting the expression of high-mobility group box 1 (HMGB1) and increase the proportion of beneficial intestinal bacteria (87).